Brokerages Set Amrize Ltd (NYSE:AMRZ) PT at $64.14

Shares of Amrize Ltd (NYSE:AMRZ) have been given a consensus recommendation of “Moderate Buy” by the seventeen brokerages that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $64.1429.

AMRZ has been the subject of several recent research reports. Bank of America set a $58.00 price target on Amrize in a report on Monday, January 12th. Sanford C. Bernstein restated an “outperform” rating and set a $70.00 price objective on shares of Amrize in a research report on Thursday, December 18th. JPMorgan Chase & Co. upped their target price on Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a research note on Thursday, March 5th. Vertical Research initiated coverage on Amrize in a research report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 target price for the company. Finally, UBS Group lifted their price target on shares of Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, January 8th.

Insider Buying and Selling at Amrize

In other Amrize news, CEO Jan Philipp Jenisch purchased 60,000 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average price of $58.05 per share, with a total value of $3,483,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,703,582 shares of the company’s stock, valued at approximately $98,892,935.10. This trade represents a 3.65% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jaime Hill purchased 3,184 shares of the business’s stock in a transaction on Monday, March 9th. The shares were acquired at an average price of $56.34 per share, with a total value of $179,386.56. Following the purchase, the insider owned 26,000 shares of the company’s stock, valued at approximately $1,464,840. This trade represents a 13.96% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased a total of 72,634 shares of company stock valued at $4,224,656 over the last quarter.

Hedge Funds Weigh In On Amrize

A number of hedge funds have recently modified their holdings of AMRZ. Public Sector Pension Investment Board boosted its stake in shares of Amrize by 8.8% in the 3rd quarter. Public Sector Pension Investment Board now owns 306,957 shares of the company’s stock valued at $14,811,000 after purchasing an additional 24,738 shares in the last quarter. Norges Bank bought a new position in Amrize in the 2nd quarter worth approximately $670,915,000. Prudential PLC acquired a new position in shares of Amrize during the second quarter valued at $754,000. Vanguard Group Inc. bought a new position in shares of Amrize in the 2nd quarter valued at about $1,065,029,000. Finally, 111 Capital bought a new position in Amrize in the third quarter valued at approximately $996,000.

Key Stories Impacting Amrize

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Significant insider buying from senior management (CEO disclosed a multi-million dollar purchase and other executives have added shares), which signals management conviction in the business. Insider Buying: Amrize CEO Acquires Stock
• Positive Sentiment: SEC filings show multiple recent purchases by the CTO, CFO and other insiders — cumulative insider accumulation increases alignment with shareholders. SEC Filing: Insider Transactions
• Positive Sentiment: Institutional buying and favorable analyst coverage (several raises/reaffirms and a “Moderate Buy” consensus) provide a constructive medium‑term backdrop. Brokerages Give AMRZ Moderate Buy
• Neutral Sentiment: Management emphasised an investment‑led growth strategy on the earnings call — positive for long term but may delay margin/near-term revenue improvements. Earnings Call Signals Investment‑Led Growth
• Negative Sentiment: Q4 revenue missed estimates (reported $2.84B vs. ~$2.95B expected) and was slightly down YoY — the top‑line miss is the main near‑term driver of weaker sentiment. MarketBeat: AMRZ Earnings/Revenue Details
• Negative Sentiment: Disclosure of a large increase in CEO compensation (reported jump year‑over‑year) could raise governance concerns for some investors. QuiverQuant: CEO 2025 Pay Revealed
• Negative Sentiment: Today’s pullback appears to be light‑volume and may reflect short‑term profit‑taking or cautious reaction to the revenue miss despite insider buys.

Amrize Stock Performance

NYSE:AMRZ opened at $56.23 on Friday. The firm’s 50-day moving average is $57.92 and its 200-day moving average is $53.64. Amrize has a 52-week low of $44.12 and a 52-week high of $65.94. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. The company has a market cap of $31.10 billion and a price-to-earnings ratio of 22.86.

Amrize (NYSE:AMRZ) last released its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.03. The company had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.95 billion. The company’s revenue was down .4% compared to the same quarter last year.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.